These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4328640)

  • 1. Sulfonylureas: effects in vivo and in vitro.
    Ann Intern Med; 1971 Oct; 75(4):607-21. PubMed ID: 4328640
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic AMP and the physiology of the islets of Langerhans.
    Montague W; Howell SL
    Adv Cyclic Nucleotide Res; 1975; 6():201-43. PubMed ID: 171928
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfonylureas and the heart.
    Levey GS; Lasseter KC; Palmer RF
    Annu Rev Med; 1974; 25():69-74. PubMed ID: 4363211
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of acid amyloglucosidase in sulphonylurea-induced insulin release.
    Lundquist I
    Diabetologia; 1974 Dec; 10(6):717-24. PubMed ID: 4374400
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of tolbutamide on adenyl cyclase in rabbit and human heart and contractility of isolated rabbit atria.
    Levey GS; Palmer RF; Lasseter KC; McCarthy J
    J Clin Endocrinol Metab; 1971 Aug; 33(2):371-4. PubMed ID: 4327691
    [No Abstract]   [Full Text] [Related]  

  • 6. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
    Grill V; Cerasi E
    J Clin Invest; 1978 May; 61(5):1346-54. PubMed ID: 207736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the action of tolbutamide in normal man. 3. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):532-44. PubMed ID: 4346919
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient neonatal diabetes: delayed maturation of the pancreatic beta cell.
    Pagliara AS; Karl IE; Kipnis DB
    J Pediatr; 1973 Jan; 82(1):97-101. PubMed ID: 4344245
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular mechanism of action of sulfonylureas].
    Ammon HP
    Dtsch Med Wochenschr; 1988 May; 113(21):864-70. PubMed ID: 3286184
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 13. The biosynthesis and secretion of insulin.
    Taylor KW
    Clin Endocrinol Metab; 1972 Nov; 1(3):601-22. PubMed ID: 4359227
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenyl cyclase and cyclic AMP-phosphodiesterase activity in the isolated islets of Langerhans of normal and obese mice.
    Atkins T; Matty AJ
    J Endocrinol; 1970 Dec; 48(4):47-8. PubMed ID: 4321277
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin release during fasting: studies on adenylate cyclase, phosphodiesterase, protein kinase, and phosphoprotein phosphatase in isolated islets of langerhans of the rat.
    Lipson LG; Siegel E; Wollheim CB; Sharp GW
    Endocrinology; 1979 Sep; 105(3):702-7. PubMed ID: 223831
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of cyclic 3',5'-AMP phosphodiesterase in islet cells and other tissues by tolbutamide.
    Goldfine ID; Perlman R; Roth J
    Nature; 1971 Dec; 234(5327):295-7. PubMed ID: 4333163
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.
    Goldner MG; Knatterud GL; Prout TE
    JAMA; 1971 Nov; 218(9):1400-10. PubMed ID: 4941698
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and morphological events associated with the development of fetal rat pancreas "in vivo" and "in vitro": effect of glucagon and of other agents.
    Lambert AE; Orci L; Kanazawa Y; Jeanrenaud B; Renold AE
    Acta Isot (Padova); 1970; 10(3):191-204. PubMed ID: 4334397
    [No Abstract]   [Full Text] [Related]  

  • 19. On the role of cyclic AMP in insulin release: I. Overall effects in cultured fetal rat pancreas.
    Lambert AE; Kanazawa Y; Burr IM; Orci L; Renold AE
    Ann N Y Acad Sci; 1971 Dec; 185():232-44. PubMed ID: 4330494
    [No Abstract]   [Full Text] [Related]  

  • 20. Borderline diabetics and their response to tolbutamide.
    Keen H; Jarrett RJ; Ward JD; Fuller JH
    Adv Metab Disord; 1973; 2():Suppl 2:521-31. PubMed ID: 4720382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.